Home ORCID in New Zealand New Zealand ORCID Consortium Who is involved Consortium Advisory Committee

New Zealand ORCID Consortium Advisory Committee

The New Zealand ORCID Consortium Advisory Committee provides feedback from Consortium members and strategic advice to the lead agency, Royal Society Te Apārangi.

Purpose and Functions of the Committee

The purpose of the New Zealand ORCID Consortium Advisory Committee is to provide a two-way conduit between members of the NZ ORCID Consortium (the Consortium) and the Royal Society Te Apārangi (the Society) for feedback and advice on strategic matters related to the use and implementation of ORCID in New Zealand.

The New Zealand ORCID Consortium Advisory Committee will:

Provide advice and guidance to the Society on matters related to the operation and future strategic direction of the Consortium to ensure success and long-term sustainability of the Consortium;
Encourage new members to join the Consortium;
Champion the use of ORCID; and
Advise on membership of the Consortium, if needed.

to 30 June 2018 Terms of Reference for the committee

to 30 June 2020 Terms of Reference for the committee

to 30 June 2022 Terms of Reference for the committee

to 31 December 2024 Terms of Reference for the committee

List of Committee members

The current membership of the New Zealand ORCID Advisory Committee is:

Marie Bradley (chair)	AgResearch
Richard Waldin	Scion
Giselle Byrnes	Massey University
Patrick Lander	Eastern Institute of Technology
Esther Viljoen	Health Research Council
Mike Wall	CONZUL (University of Otago)
Angela Hannah	MBIE
Alex Martin	Medical Research Institute of New Zealand (ECR representative)
Katharina Ruckstuhl	University of Otago
Marina Dzhelali	Capital & Coast District Health Board

Te Ara Paerangi | Future Pathways Submission

The Advisory Committee of the New Zealand ORCID Consortium submitted to the Te Ara Paerangi | Future Pathways green paper, emphasising the importance of research infrastructure in Aotearoa.

Read the submission.